Protalix BioTherapeutics' (PLX) Alfataliglicerase Approved in Brazil for the Treatment of Certain Gaucher Disease
Go back to Protalix BioTherapeutics' (PLX) Alfataliglicerase Approved in Brazil for the Treatment of Certain Gaucher Disease| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 1.19 -0.02 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.21 | 52 Week High | $1.11 | |||
| Open | $1.21 | 52 Week Low | $0.41 | |||
| Day High | $1.21 | P/E | N/A | |||
| Day Low | $1.16 | EPS | $-0.29 | |||
| Volume | 90,566 | |||||
